中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
14期
71-73
,共3页
附子理中丸%帕罗西汀%腹泻型肠易综合征
附子理中汍%帕囉西汀%腹瀉型腸易綜閤徵
부자리중환%파라서정%복사형장역종합정
The Fuzi Lizhong wan%Bifico%IBS
目的：探讨附子理中丸联用帕罗西汀、培菲康用于腹泻型肠易激综合征治疗的效果。方法：将78例腹泻型肠易激综合征（IBS）患者分组。观察组：服用附子理中丸、培菲康及帕罗西汀；对照组给予培菲康、帕罗西汀，比较两组疗效。结果：两组治疗均可改善患者症状，治疗组有效率（89.74%）优于对照组（74.36%）；观察组肛管静息压、HAMA评分及直肠最大感觉阈值较对照组，有明显差异（P<0.05）。结论：附子理中丸、培菲康及帕罗西汀用于治疗腹泻型肠易激综合征效果显著。
目的：探討附子理中汍聯用帕囉西汀、培菲康用于腹瀉型腸易激綜閤徵治療的效果。方法：將78例腹瀉型腸易激綜閤徵（IBS）患者分組。觀察組：服用附子理中汍、培菲康及帕囉西汀；對照組給予培菲康、帕囉西汀，比較兩組療效。結果：兩組治療均可改善患者癥狀，治療組有效率（89.74%）優于對照組（74.36%）；觀察組肛管靜息壓、HAMA評分及直腸最大感覺閾值較對照組，有明顯差異（P<0.05）。結論：附子理中汍、培菲康及帕囉西汀用于治療腹瀉型腸易激綜閤徵效果顯著。
목적：탐토부자리중환련용파라서정、배비강용우복사형장역격종합정치료적효과。방법：장78례복사형장역격종합정（IBS）환자분조。관찰조：복용부자리중환、배비강급파라서정；대조조급여배비강、파라서정，비교량조료효。결과：량조치료균가개선환자증상，치료조유효솔（89.74%）우우대조조（74.36%）；관찰조항관정식압、HAMA평분급직장최대감각역치교대조조，유명현차이（P<0.05）。결론：부자리중환、배비강급파라서정용우치료복사형장역격종합정효과현저。
Objective:To explore efficacy of the Fuzi Lizhong Wan plus Bifico, Aroxetine on IBS. Methods:78 patients with IBS were divided into the observed group given the Fuzi Lizhong Wan plus Bifico, Aroxetine and the control group given Bifico, Aroxetine, with comparing efficacy in both groups. Results: After the treatment, symptoms in both groups were improved. The efficiency in the observed group (89.74%) was better than that in the control group (74.36%). Anal resting pressure, HAMA, maximum rectal sensory thresholds in the observed group was better, with an obvious difference (P<0.05). Conclusion:Treating IBS with Fuzi Lizhong Wan plus Bifico, Aroxetine could obtain significant efficacy.
